FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q2 2015 13F Holders as of 30 Jun 2015
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 18,018,637
- Share change
- +7,409,855
- Total reported value
- $116,577,000
- Price per share
- $6.47
- Number of holders
- 37
- Value change
- +$48,004,684
- Number of buys
- 32
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
2.5%
|
3,095,582
|
$15,137,000 | — | 31 Mar 2015 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
2%
|
2,473,186
|
$12,094,000 | — | 31 Mar 2015 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.2%
|
1,523,275
|
$7,449,000 | — | 31 Mar 2015 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.2%
|
1,457,698
|
$7,128,000 | — | 31 Mar 2015 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.57%
|
692,900
|
$3,388,000 | — | 31 Mar 2015 | |
| HIGHLAND CAPITAL MANAGEMENT LP |
13F
|
Company |
0.27%
|
328,188
|
$1,605,000 | — | 31 Mar 2015 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.24%
|
291,067
|
$1,423,000 | — | 31 Mar 2015 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.17%
|
209,600
|
$1,025,000 | — | 31 Mar 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.15%
|
180,638
|
$883,000 | — | 31 Mar 2015 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.07%
|
82,563
|
$404,000 | — | 31 Mar 2015 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.06%
|
70,428
|
$344,000 | — | 31 Mar 2015 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
38,400
|
$188,000 | — | 31 Mar 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
37,013
|
$181,000 | — | 31 Mar 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
31,576
|
$154,000 | — | 31 Mar 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.02%
|
22,406
|
$110,000 | — | 31 Mar 2015 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.02%
|
20,190
|
$99,000 | — | 31 Mar 2015 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
14,900
|
$73,000 | — | 31 Mar 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
14,770
|
$72,000 | — | 31 Mar 2015 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
12,800
|
$61,000 | — | 31 Mar 2015 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,443
|
$17,000 | — | 31 Mar 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
2,179
|
$11,000 | — | 31 Mar 2015 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
2,000
|
$10,000 | — | 31 Mar 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,000
|
$10,000 | — | 31 Mar 2015 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
980
|
$5,000 | — | 31 Mar 2015 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 31 Mar 2015 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2015
As of 30 Jun 2015,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,018,637 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, Broadfin Capital, LLC, HIGHLAND CAPITAL MANAGEMENT LP, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, and PRINCIPAL FINANCIAL GROUP INC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2015 vs Q1 2015 Across Filers
Q1 2015 holders
25
Q2 2015 holders
37
Holder diff
12
| Investor | Q1 2015 Shares | Q2 2015 Shares | Share Diff | Share Chg % | Q1 2015 Value $ | Q2 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.